Current status of intragastric balloon for obesity treatment

World Journal of Gastroenterology

Volumn 22, Issue 24, 2016, Pages 5495-5504

  Kim, Seung Han ^a   Chun, Hoon Jai ^a   Choi, Hyuk Soon ^a   Kim, Eun Sun ^a   Keum, Bora ^a   Jeen, Yoon Tae ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Bariatric; Endoscopy; Intragastric balloon; Metabolic; Obesity

Indexed keywords

GASTROINTESTINAL HORMONE;

ABDOMINAL PAIN; ADJUSTABLE TOTALLY IMPLANTABLE INTRAGASTRIC PROSTHESIS; BALLOON MIGRATION; CLINICAL EFFECTIVENESS; COMORBIDITY; DEVICE APPROVAL; DEVICE REMOVAL; DEVICE SAFETY; DEVICE THERAPY; DIET THERAPY; DISEASE SEVERITY; EARLY INTERVENTION; ENDOSCOPIC SURGERY; FLUOROSCOPY; GASTRIC BALLOON; GASTROESOPHAGEAL REFLUX; HUMAN; KINESIOTHERAPY; LIFESTYLE MODIFICATION; METABOLIC DISORDER; MORBID OBESITY; NAUSEA; NONALCOHOLIC FATTY LIVER; OBESITY; OUTCOME ASSESSMENT; PAIN; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SATIETY; SILICONE PROSTHESIS; SMALL INTESTINE OBSTRUCTION; SMALL INTESTINE PERFORATION; STOMACH EMPTYING; STOMACH ULCER; TREATMENT DURATION; TREATMENT INDICATION; VOMITING; WEIGHT REDUCTION; BARIATRIC SURGERY; GASTROSCOPY; OBESITY, MORBID;

BARIATRIC SURGERY; GASTRIC BALLOON; GASTROSCOPY; HUMANS; OBESITY; OBESITY, MORBID;

EID: 84979072458     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i24.5495     Document Type: Review

References (86)

1. Pi-Sunyer X. The medical risks of obesity. Postgrad Med 2009; 121: 21-33 [PMID: 19940414 DOI: 10.3810/pgm.2009.11.2074]
2. Gregg EW, Chen H, Wagenknecht LE, Clark JM, Delahanty LM, Bantle J, Pownall HJ, Johnson KC, Safford MM, Kitabchi AE, Pi-Sunyer FX, Wing RR, Bertoni AG. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 2012; 308: 2489-2496 [PMID: 23288372 DOI: 10.1001/jama.2012.67929]
3. Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009; 374: 1677-1686 [PMID: 19878986 DOI: 10.1016/S0140-6736(09)61457-4]
4. Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: The look AHEAD study. Obesity (Silver Spring) 2014; 22: 5-13 [PMID: 24307184 DOI: 10.1002/oby.20662]
5. Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: A systematic and clinical review. JAMA 2014; 311: 74-86 [PMID: 24231879 DOI: 10.1001/jama.2013.281361]
6. Patel D. Pharmacotherapy for the management of obesity. Metabolism 2015; 64: 1376-1385 [PMID: 26342499 DOI: 10.1016/j.metabol.2015.08.001]
7. Rankin W, Wittert G. Anti-obesity drugs. Curr Opin Lipidol 2015; 26: 536-543 [PMID: 26382553 DOI: 10.1097/MOL.0000000 000000232]
8. Fujioka K. Current and emerging medications for overweight or obesity in people with comorbidities. Diabetes Obes Metab 2015; 17: 1021-1032 [PMID: 26040215 DOI: 10.1111/dom.12502]
9. Ochner CN, Gibson C, Carnell S, Dambkowski C, Geliebter A. The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity. Physiol Behav 2010; 100: 549-559 [PMID: 20452367 DOI: 10.1016/j.physbeh.2010.04.032]
10. Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: An updated systematic review and meta-analysis, 2003-2012. JAMA Surg 2014; 149: 275-287 [PMID: 24352617 DOI: 10.1001/jamasurg.2013.3654]
11. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg 2013; 23: 427-436 [PMID: 23338049 DOI: 10.1007/s11695-012-0864-0]
12. Gleysteen JJ. A history of intragastric balloons. Surg Obes Relat Dis 2016; 12: 430-435 [PMID: 26775045 DOI: 10.1016/j.soard.2015.10.074]
13. Abu Dayyeh BK, Kumar N, Edmundowicz SA, Jonnalagadda S, Larsen M, Sullivan S, Thompson CC, Banerjee S. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc 2015; 82: 425-438.e5 [PMID: 26232362 DOI: 10.1016/j.gie.2015.03.1964]
14. Mathus-Vliegen EM. Endoscopic treatment: The past, the present and the future. Best Pract Res Clin Gastroenterol 2014; 28: 685-702 [PMID: 25194184 DOI: 10.1016/j.bpg.2014.07.009]
15. Geliebter A, Westreich S, Gage D. Gastric distention by balloon and test-meal intake in obese and lean subjects. Am J Clin Nutr 1988; 48: 592-594 [PMID: 3414573]
16. Geliebter A, Melton PM, McCray RS, Gage D, Heymsfield SB, Abiri M, Hashim SA. Clinical trial of silicone-rubber gastric balloon to treat obesity. Int J Obes 1991; 15: 259-266 [PMID: 2071316]
17. Mathus-Vliegen EM, Eichenberger RI. Fasting and mealsuppressed ghrelin levels before and after intragastric balloons and balloon-induced weight loss. Obes Surg 2014; 24: 85-94 [PMID: 23918282 DOI: 10.1007/s11695-013-1053-5]
18. Mathus-Vliegen EM, de Groot GH. Fasting and meal-induced CCK and PP secretion following intragastric balloon treatment for obesity. Obes Surg 2013; 23: 622-633 [PMID: 23224567 DOI: 10.1007/s11695-012-0834-6]
19. Machytka E, Chuttani R, Bojkova M, Kupka T, Buzga M, Stecco K, Levy S, Gaur S. Elipse™, a Procedureless Gastric Balloon for Weight Loss: A Proof-of-Concept Pilot Study. Obes Surg 2016; 26: 512-516 [PMID: 26253980 DOI: 10.1007/s11695-015-1783-7]
20. Mion F, Gincul R, Roman S, Beorchia S, Hedelius F, Claudel N, Bory RM, Malvoisin E, Trepo F, Napoleon B. Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: Results of a prospective multicenter study. Obes Surg 2007; 17: 764-769 [PMID: 17879576]
21. Forestieri P, De Palma GD, Formato A, Giuliano ME, Monda A, Pilone V, Romano A, Tramontano S. Heliosphere Bag in the treatment of severe obesity: Preliminary experience. Obes Surg 2006; 16: 635-637 [PMID: 16687034 DOI: 10.1381/09608920677 6945156]
22. De Castro ML, Morales MJ, Del Campo V, Pineda JR, Pena E, Sierra JM, Arbones MJ, Prada IR. Efficacy, safety, and tolerance of two types of intragastric balloons placed in obese subjects: A double-blind comparative study. Obes Surg 2010; 20: 1642-1646 [PMID: 20390374 DOI: 10.1007/s11695-010-0128-9]
23. Giardiello C, Borrelli A, Silvestri E, Antognozzi V, Iodice G, Lorenzo M. Air-filled vs water-filled intragastric balloon: A prospective randomized study. Obes Surg 2012; 22: 1916-1919 [PMID: 23054576 DOI: 10.1007/s11695-012-0786-x]
24. Carvalho GL, Barros CB, Okazaki M, Novaes ML, Albuquerque PC, Almeida NC, Albuquerque PP, Wakiyama C, Vilaça TG, Silva JS, Coelho RM. An improved intragastric balloon procedure using a new balloon: Preliminary analysis of safety and efficiency. Obes Surg 2009; 19: 237-242 [PMID: 18581191 DOI: 10.1007/s11695-008-9592-x]
25. Gaggiotti G, Tack J, Garrido AB, Palau M, Cappelluti G, Di Matteo F. Adjustable totally implantable intragastric prosthesis (ATIIP)-Endogast for treatment of morbid obesity: One-year followup of a multicenter prospective clinical survey. Obes Surg 2007; 17: 949-956 [PMID: 17894156 DOI: 10.1007/s11695-007-9174-3]
26. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW. Bodymass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-1105 [PMID: 10511607 DOI: 10.1056/NEJM199910073411501]
27. Mitura K, Garnysz K. In search of the ideal patient for the intragastric balloon-short-and long-term results in 70 obese patients. Wideochir Inne Tech Maloinwazyjne 2016; 10: 541-547 [PMID: 26865890 DOI: 10.5114/wiitm.2015.55748]
28. Ginsberg GG, Chand B, Cote GA, Dallal RM, Edmundowicz SA, Nguyen NT, Pryor A, Thompson CC. A pathway to endoscopic bariatric therapies. Gastrointest Endosc 2011; 74: 943-953 [PMID: 22032311 DOI: 10.1016/j.gie.2011.08.053]
29. Poobalan A, Aucott L, Smith WC, Avenell A, Jung R, Broom J, Grant AM. Effects of weight loss in overweight/obese individuals and long-term lipid outcomes-A systematic review. Obes Rev 2004; 5: 43-50 [PMID: 14969506 DOI: 10.1111/j.1467-789X.2004.00127.x]
30. Poobalan AS, Aucott LS, Smith WC, Avenell A, Jung R, Broom J. Long-term weight loss effects on all cause mortality in overweight/obese populations. Obes Rev 2007; 8: 503-513 [PMID: 17949355 DOI: 10.1111/j.1467-789X.2007.00393.x]
31. Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg 2008; 18: 1611-1617 [PMID: 18568377 DOI: 10.1007/s11695-008-9593-9]
32. Phillips RJ, Powley TL. Gastric volume rather than nutrient content inhibits food intake. Am J Physiol 1996; 271: R766-R769 [PMID: 8853402]
33. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660 [PMID: 10604470]
34. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 1623-1630 [PMID: 12023994 DOI: 10.1056/Nejmoa012908]
35. Bonazzi P, Petrelli MD, Lorenzini I, Peruzzi E, Nicolai A, Galeazzi R. Gastric emptying and intragastric balloon in obese patients. Eur Rev Med Pharmacol Sci 2005; 9: 15-21 [PMID: 16457125]
36. Genco A, Balducci S, Bacci V, Materia A, Cipriano M, Baglio G, Ribaudo MC, Maselli R, Lorenzo M, Basso N. Intragastric balloon or diet alone? A retrospective evaluation. Obes Surg 2008; 18: 989-992 [PMID: 18483834 DOI: 10.1007/s11695-007-9383-9]
37. Genco A, Cipriano M, Materia A, Bacci V, Maselli R, Musmeci L, Lorenzo M, Basso N. Laparoscopic sleeve gastrectomy versus intragastric balloon: A case-control study. Surg Endosc 2009; 23: 1849-1853 [PMID: 19169745 DOI: 10.1007/s00464-008-0285-2]
38. Göttig S, Daskalakis M, Weiner S, Weiner RA. Analysis of safety and efficacy of intragastric balloon in extremely obese patients. Obes Surg 2009; 19: 677-683 [PMID: 19291338 DOI: 10.1007/s11695-009-9820-z]
39. Konopko-Zubrzycka M, Baniukiewicz A, Wróblewski E, Kowalska I, Zarzycki W, Górska M, Dabrowski A. The effect of intragastric balloon on plasma ghrelin, leptin, and adiponectin levels in patients with morbid obesity. J Clin Endocrinol Metab 2009; 94: 1644-1649 [PMID: 19258408 DOI: 10.1210/jc.2008-1083]
40. Ohta M, Kitano S, Kai S, Shiromizu A, Eguchi H, Endo Y, Masaki T, Kakuma T, Yoshimatsu H. Initial Japanese experience with intragastric balloon placement. Obes Surg 2009; 19: 791-795 [PMID: 18592329 DOI: 10.1007/s11695-008-9612-x]
41. Coskun H, Bostanci O. Assessment of the application of the intragastric balloon together with sibutramine: A prospective clinical study. Obes Surg 2010; 20: 1117-1120 [PMID: 18712574 DOI: 10.1007/s11695-008-9662-0]
42. Mui WL, Ng EK, Tsung BY, Lam CH, Yung MY. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg 2010; 20: 1128-1132 [PMID: 19015930 DOI: 10.1007/s11695-008-9766-6]
43. Lopez-Nava G, Rubio MA, Prados S, Pastor G, Cruz MR, Companioni E, Lopez A. BioEnterics® intragastric balloon (BIB®). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg 2011; 21: 5-9 [PMID: 20306153 DOI: 10.1007/s11695-010-0093-3]
44. Kotzampassi K, Grosomanidis V, Papakostas P, Penna S, Eleftheriadis E. 500 intragastric balloons: What happens 5 years thereafter? Obes Surg 2012; 22: 896-903 [PMID: 22287051 DOI: 10.1007/s11695-012-0607-2]
45. Papavramidis TS, Grosomanidis V, Papakostas P, Penna S, Kotzampassi K. Intragastric balloon fundal or antral position affects weight loss and tolerability. Obes Surg 2012; 22: 904-909 [PMID: 22322378 DOI: 10.1007/s11695-012-0620-5]
46. Genco A, Dellepiane D, Baglio G, Cappelletti F, Frangella F, Maselli R, Dante MC, Camoirano R, Lorenzo M, Basso N. Adjustable intragastric balloon vs non-adjustable intragastric balloon: Case-control study on complications, tolerance, and efficacy. Obes Surg 2013; 23: 953-958 [PMID: 23526067 DOI: 10.1007/s11695-013-0891-5]
47. Gümürdülü Y, Dogan UB, Akin MS, Tasdogan BE, Yalaki S. Long-term effectiveness of BioEnterics intragastric balloon in obese patients. Turk J Gastroenterol 2013; 24: 387-391 [PMID: 24557961 DOI: 10.4318/tjg.2013.0696]
48. Fuller NR, Lau NS, Denyer G, Caterson ID. An intragastric balloon produces large weight losses in the absence of a change in ghrelin or peptide YY. Clin Obes 2013; 3: 172-179 [PMID: 25586733 DOI: 10.1111/cob.12030]
49. Totté E, Hendrickx L, Pauwels M, Van Hee R. Weight reduction by means of intragastric device: Experience with the bioenterics intragastric balloon. Obes Surg 2001; 11: 519-523 [PMID: 11501367]
50. Sallet JA, Marchesini JB, Paiva DS, Komoto K, Pizani CE, Ribeiro ML, Miguel P, Ferraz AM, Sallet PC. Brazilian multicenter study of the intragastric balloon. Obes Surg 2004; 14: 991-998 [PMID: 15329191 DOI: 10.1381/0960892041719671]
51. Crea N, Pata G, Della Casa D, Minelli L, Maifredi G, Di Betta E, Mittempergher F. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg 2009; 19: 1084-1088 [PMID: 19506981 DOI: 10.1007/s11695-009-9879-6]
52. Fuller NR, Pearson S, Lau NS, Wlodarczyk J, Halstead MB, Tee HP, Chettiar R, Kaffes AJ. An intragastric balloon in the treatment of obese individuals with metabolic syndrome: A randomized controlled study. Obesity (Silver Spring) 2013; 21: 1561-1570 [PMID: 23512773 DOI: 10.1002/oby.20414]
53. Al Kahtani K, Khan MQ, Helmy A, Al Ashgar H, Rezeig M, Al Quaiz M, Kagevi I, Al Sofayan M, Al Fadda M. Bio-enteric intragastric balloon in obese patients: A retrospective analysis of King Faisal Specialist Hospital experience. Obes Surg 2010; 20: 1219-1226 [PMID: 18752030 DOI: 10.1007/s11695-008-9654-0]
54. Genco A, López-Nava G, Wahlen C, Maselli R, Cipriano M, Sanchez MM, Jacobs C, Lorenzo M. Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience. Obes Surg 2013; 23: 515-521 [PMID: 23224509 DOI: 10.1007/s11695-012-0829-3]
55. Herve J, Wahlen CH, Schaeken A, Dallemagne B, Dewandre JM, Markiewicz S, Monami B, Weerts J, Jehaes C. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg 2005; 15: 864-870 [PMID: 15978160 DOI: 10.1381/09 60892054222894]
56. Tai CM, Lin HY, Yen YC, Huang CK, Hsu WL, Huang YW, Chang CY, Wang HP, Mo LR. Effectiveness of intragastric balloon treatment for obese patients: One-year follow-up after balloon removal. Obes Surg 2013; 23: 2068-2074 [PMID: 23832520 DOI: 10.1007/s11695-013-1027-7]
57. Dastis NS, François E, Deviere J, Hittelet A, Ilah Mehdi A, Barea M, Dumonceau JM. Intragastric balloon for weight loss: Results in 100 individuals followed for at least 2.5 years. Endoscopy 2009; 41: 575-580 [PMID: 19588283 DOI: 10.1055/s-0029-1214826]
58. Gaur S, Levy S, Mathus-Vliegen L, Chuttani R. Balancing risk and reward: A critical review of the intragastric balloon for weight loss. Gastrointest Endosc 2015; 81: 1330-1336 [PMID: 25887720 DOI: 10.1016/j.gie.2015.01.054]
59. Dogan UB, Gumurdulu Y, Akin MS, Yalaki S. Five percent weight lost in the first month of intragastric balloon treatment may be a predictor for long-term weight maintenance. Obes Surg 2013; 23: 892-896 [PMID: 23404240 DOI: 10.1007/s11695-013-0876-4]
60. Lopez-Nava G, Bautista-Castaño I, Jimenez-Baños A, Fernandez-Corbelle JP. Dual Intragastric Balloon: Single Ambulatory Center Spanish Experience with 60 Patients in Endoscopic Weight Loss Management. Obes Surg 2015; 25: 2263-2267 [PMID: 25982804 DOI: 10.1007/s11695-015-1715-6]
61. Ponce J, Quebbemann BB, Patterson EJ. Prospective, randomized, multicenter study evaluating safety and efficacy of intragastric dual-balloon in obesity. Surg Obes Relat Dis 2013; 9: 290-295 [PMID: 22951075 DOI: 10.1016/j.soard.2012.07.007]
62. Ponce J, Woodman G, Swain J, Wilson E, English W, Ikramuddin S, Bour E, Edmundowicz S, Snyder B, Soto F, Sullivan S, Holcomb R, Lehmann J. The REDUCE pivotal trial: A prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis 2015; 11: 874-881 [PMID: 25868829 DOI: 10.1016/j.soard.2014.12.006]
63. Machytka E, Klvana P, Kornbluth A, Peikin S, Mathus-Vliegen LE, Gostout C, Lopez-Nava G, Shikora S, Brooks J. Adjustable intragastric balloons: A 12-month pilot trial in endoscopic weight loss management. Obes Surg 2011; 21: 1499-1507 [PMID: 21553304 DOI: 10.1007/s11695-011-0424-z]
64. Brooks J, Srivastava ED, Mathus-Vliegen EM. One-year adjustable intragastric balloons: Results in 73 consecutive patients in the U.K. Obes Surg 2014; 24: 813-819 [PMID: 24442419 DOI: 10.1007/s11695-014-1176-3]
65. Carvalho GL, Barros CB, Moraes CE, Okazaki M, Ferreira Mde N, Silva JS, de Albuquerque PP, Coelho Rde M. The use of an improved intragastric balloon technique to reduce weight in preobese patients-preliminary results. Obes Surg 2011; 21: 924-927 [PMID: 19756895 DOI: 10.1007/s11695-009-9947-y]
66. Mion F, Ibrahim M, Marjoux S, Ponchon T, Dugardeyn S, Roman S, Deviere J. Swallowable Obalon® gastric balloons as an aid for weight loss: A pilot feasibility study. Obes Surg 2013; 23: 730-733 [PMID: 23512445 DOI: 10.1007/s11695-013-0927-x]
67. Farina MG, Baratta R, Nigro A, Vinciguerra F, Puglisi C, Schembri R, Virgilio C, Vigneri R, Frittitta L. Intragastric balloon in association with lifestyle and/or pharmacotherapy in the longterm management of obesity. Obes Surg 2012; 22: 565-571 [PMID: 21901285 DOI: 10.1007/s11695-011-0514-y]
68. Imaz I, Martínez-Cervell C, García-Alvarez EE, Sendra-Gutiérrez JM, González-Enríquez J. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg 2008; 18: 841-846 [PMID: 18459025 DOI: 10.1007/s11695-007-9331-8]
69. Forlano R, Ippolito AM, Iacobellis A, Merla A, Valvano MR, Niro G, Annese V, Andriulli A. Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients. Gastrointest Endosc 2010; 71: 927-933 [PMID: 19863955 DOI: 10.1016/j.gie.2009.06.036]
70. Angrisani L, Lorenzo M, Borrelli V, Giuffré M, Fonderico C, Capece G. Is bariatric surgery necessary after intragastric balloon treatment? Obes Surg 2006; 16: 1135-1137 [PMID: 16989695 DOI: 10.1381/096089206778392365]
71. Mathus-Vliegen EM. Intragastric balloon treatment for obesity: What does it really offer? Dig Dis 2008; 26: 40-44 [PMID: 18600014 DOI: 10.1159/000109385]
72. Ganesh R, Rao AD, Baladas HG, Leese T. The Bioenteric Intragastric Balloon (BIB) as a treatment for obesity: Poor results in Asian patients. Singapore Med J 2007; 48: 227-231 [PMID: 17342292]
73. Younossi ZM, Diehl AM, Ong JP. Nonalcoholic fatty liver disease: An agenda for clinical research. Hepatology 2002; 35: 746-752 [PMID: 11915019 DOI: 10.1053/jhep.2002.32483]
74. Lee YM, Low HC, Lim LG, Dan YY, Aung MO, Cheng CL, Wee A, Lim SG, Ho KY. Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: A pilot study. Gastrointest Endosc 2012; 76: 756-760 [PMID: 22840293 DOI: 10.1016/j.gie.2012.05.023]
75. Ochner CN, Kwok Y, Conceição E, Pantazatos SP, Puma LM, Carnell S, Teixeira J, Hirsch J, Geliebter A. Selective reduction in neural responses to high calorie foods following gastric bypass surgery. Ann Surg 2011; 253: 502-507 [PMID: 21169809 DOI: 10.1097/SLA.0b013e318203a289]
76. Wren AM, Bloom SR. Gut hormones and appetite control. Gastroenterology 2007; 132: 2116-2130 [PMID: 17498507 DOI: 10.1053/j.gastro.2007.03.048]
77. Delzenne N, Blundell J, Brouns F, Cunningham K, De Graaf K, Erkner A, Lluch A, Mars M, Peters HP, Westerterp-Plantenga M. Gastrointestinal targets of appetite regulation in humans. Obes Rev 2010; 11: 234-250 [PMID: 20433660 DOI: 10.1111/j.1467-789X.2009.00707.x]
78. Mion F, Napoléon B, Roman S, Malvoisin E, Trepo F, Pujol B, Lefort C, Bory RM. Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients. Obes Surg 2005; 15: 510-516 [PMID: 15946431 DOI: 10.1381/09 60892053723411]
79. Martinez-Brocca MA, Belda O, Parejo J, Jimenez L, del Valle A, Pereira JL, Garcia-Pesquera F, Astorga R, Leal-Cerro A, Garcia-Luna PP. Intragastric balloon-induced satiety is not mediated by modification in fasting or postprandial plasma ghrelin levels in morbid obesity. Obes Surg 2007; 17: 649-657 [PMID: 17658025]
80. Greenway FL. Physiological adaptations to weight loss and factors favouring weight regain. Int J Obes (Lond) 2015; 39: 1188-1196 [PMID: 25896063 DOI: 10.1038/ijo.2015.59]
81. Crujeiras AB, Goyenechea E, Abete I, Lage M, Carreira MC, Martínez JA, Casanueva FF. Weight regain after a diet-induced loss is predicted by higher baseline leptin and lower ghrelin plasma levels. J Clin Endocrinol Metab 2010; 95: 5037-5044 [PMID: 20719836 DOI: 10.1210/jc.2009-2566]
82. Abu Dayyeh BK, Edmundowicz SA, Jonnalagadda S, Kumar N, Larsen M, Sullivan S, Thompson CC, Banerjee S. Endoscopic bariatric therapies. Gastrointest Endosc 2015; 81: 1073-1086 [PMID: 25828245 DOI: 10.1016/j.gie.2015.02.023]
83. Kim SH, Chun HJ. Endoscopic Treatment for Obesity: New Emerging Technology Trends. Gut Liver 2015; 9: 431-432 [PMID: 26087857 DOI: 10.5009/gnl15125]
84. Dai SC, Paley M, Chandrasekhara V. Intragastric balloons: An introduction and removal technique for the endoscopist. Gastrointest Endosc 2015; 82: 1122 [PMID: 26183825 DOI: 10.1016/j.gie.2015.06.008]
85. Bužga M, Evžen M, Pavel K, Tomáš K, Vladislava Z, Pavel Z, Svagera Z. Effects of the intragastric balloon MedSil on weight loss, fat tissue, lipid metabolism, and hormones involved in energy balance. Obes Surg 2014; 24: 909-915 [PMID: 24488758 DOI: 10.1007/s11695-014-1191-4]
86. Nikolic M, Boban M, Ljubicic N, Supanc V, Mirosevic G, Pezo Nikolic B, Krpan R, Posavec L, Zjacic-Rotkvic V, Bekavac-Beslin M, Gacina P. Morbidly obese are ghrelin and leptin hyporesponders with lesser intragastric balloon treatment efficiency: Ghrelin and leptin changes in relation to obesity treatment. Obes Surg 2011; 21: 1597-1604 [PMID: 21494811 DOI: 10.1007/s11695-011-0414-1]